Table 2.
Distribution of hBoV, hMPV, and InfA-B of single and co-infections in subjects with ILI (n = 116) by age.
| InfA/B n (%) | hMPV n (%) | hBoV n (%) | Total n (%) | P value |
|||
|---|---|---|---|---|---|---|---|
| Flu A/B vs hMPV | Flu A/B vs hBoV | hMPV vs hBoV | |||||
| Age | |||||||
| 0–14 (yrs) | 21 (51.2) | 16 (72.7) | 29 (54.7) | 52 (44.8) | 0.4126 | 0.1695 | 0.0175 |
| 15–64 (yrs) | 8 (19.5) | 3 (13.6) | 10 (18.9) | 22 (19.0) | 0.1623 | 0.7591 | 0.0452 |
| > 64 (yrs) | 12 (29.3) | 3 (13.6) | 14 (26.4) | 42 (36.2) | 0.0204 | 0.8134 | 0.0055 |
| Total | 41 (35.3) | 22 (19.0) | 53 (45.7) | ||||
| Single and co-infections | |||||||
| Total | 41 (35.3) | 22 (19.0) | 53 (45.7) | – | 0.0079 | 0.1413 | 0.0001 |
| Single infections | 16 (39.0) | 4 (18.2) | 27 (50.9) | 47 (40.5) | 0.1547 | 0.3464 | 0.0104 |
| Double infections | 18 (43.9) | 11 (50.0) | 19 (35.8) | 24 (20.7) | 0.0902 | 0.2500 | 0.0104 |
| Flu A/B | – | 5 (45.5) | 13 (68.4) | – | – | – | – |
| hMPV | 5 (27.8) | – | 6 (31.6) | – | – | – | – |
| hBoV | 13 (72.2) | 6 (54.5) | – | – | – | – | – |
| Triple infections | 7 (17.1) | 7 (31.8) | 7 (13.2) | – | – | – | – |